Initially approved to treat type 2 diabetes, Ozempic and Mounjaro also can help people with type 1 diabetes lose weight and control their blood sugar levels, a new study finds.
. Type 1 diabetics lost an average of 9% of their body weight on Ozempic, and more than 21%, on average, with Mounjaro.
Similarly, 47% of Ozempic users and 87% of Mounjaro users lost at least 10% of their body weight – something not achieved by anyone in the control group.has been seen in other studies of these drugs and is likely to lower the risk of a number of consequences oftype 1 diabetes
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
How Ozempic, Wegovy, Mounjaro, Zepbound May Help Treat Other Diseases: Here’s What To KnowArianna Johnson is a reporter on the Forbes news desk who covers explainers and trends, with a frequent focus on health and science. She joined Forbes in 2022 and works in Texas. Johnson has covered prominent weight loss drugs like Ozempic and Wegovy, the health effects of the artificial sweetener aspartame and the impacts of the Covid vaccines.
Read more »
Mounjaro, Zepbound Cut Odds for Diabetes by 94% in At-Risk People, Study FindsTirzepatide, the blockbuster GLP-1 medicine known as Mounjaro for diabetes and Zepbound for weight loss, cut the odds that an obese, prediabetic person will develop diabetes by 94%, a new trial shows.
Read more »
People Are Overdosing on Semaglutide Drugs like Ozempic and WegovyDosing errors in the medication semaglutide, prescribed as Wegovy and Ozempic, can cause severe or prolonged gastrointestinal issues that require medical attention
Read more »
Mounjaro/Zepbound Drastically Cuts Risk Of Type 2 Diabetes, Eli Lilly Report SuggestsArianna Johnson is a reporter on the Forbes news desk who covers explainers and trends, with a frequent focus on health and science. She joined Forbes in 2022 and works in Texas. Johnson has covered prominent weight loss drugs like Ozempic and Wegovy, the health effects of the artificial sweetener aspartame and the impacts of the Covid vaccines.
Read more »
Taking Mounjaro Reduces Risk of Developing Diabetes by 94 Percent in Three-Year TrialScience and Technology News and Videos
Read more »
Women Taking Mounjaro And Zepbound Lose More Weight Than Men, New Study Suggests: What To KnowArianna Johnson is a reporter on the Forbes news desk who covers explainers and trends, with a frequent focus on health and science. She joined Forbes in 2022 and works in Texas. Johnson has covered prominent weight loss drugs like Ozempic and Wegovy, the health effects of the artificial sweetener aspartame and the impacts of the Covid vaccines.
Read more »